Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial / Isidori, Am; Venneri, Ma; Graziadio, C; Simeoli, C; Fiore, D; Hasenmajer, V; Sbardella, E; Gianfrilli, D; Pozza, C; Pasqualetti, P; Morrone, S; Santoni, A; Naro, F; Colao, A; Pivonello, R; Lenzi, A.. - In: THE LANCET DIABETES & ENDOCRINOLOGY. - ISSN 2213-8587. - (2017).

Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.

Simeoli C;Colao A;Pivonello R;
2017

2017
Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial / Isidori, Am; Venneri, Ma; Graziadio, C; Simeoli, C; Fiore, D; Hasenmajer, V; Sbardella, E; Gianfrilli, D; Pozza, C; Pasqualetti, P; Morrone, S; Santoni, A; Naro, F; Colao, A; Pivonello, R; Lenzi, A.. - In: THE LANCET DIABETES & ENDOCRINOLOGY. - ISSN 2213-8587. - (2017).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/703632
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 148
social impact